Search Prime Grants

U24HG004059

Cooperative Agreement

Overview

Grant Description
Bioconductor: An Open-Source, Open-Development Computing Resource for Genomics - Project Summary

Bioconductor is a project dedicated to the analysis and interpretation of high throughput genomic data, including sequencing, microarray, flow cytometry, proteomics, and imaging data. Bioconductor is based on the R statistical programming language. It consists of software, annotation, and data packages developed and contributed by individuals funded by this grant, and by the national and international scientific community.

Bioconductor is highly respected, widely used in the global bioinformatics community, highly cited, and has formal collaborative alignments with the Human Cell Atlas and NHGRI's Genomic Analysis, Visualization, and Informatics Lab Space (ANVIL).

Work proposed in this renewal application reflects the commitment of the project to open-source/open-development creation and distribution of portable tools for genomic data science, high-quality documentation and support for users and developers, adaptation of computational methods to new technologies for cloud-scale data science, and effective training of the workforce for genome biology and personalized genomic medicine.

The specific aims are:

1. Maintenance and enhancement of the system at Bioconductor.org for organizing and distributing analytic software, reference data, and curated experimental data.

2. Hardening of core infrastructural software packages to increase reliability and throughput of analyses based on the system.

3. Conduct research and development of best practices for taking advantage of scalable computing strategies for integrative cloud-scale genomic analysis.

4. Enhance community engagement and education practices that have been intrinsic to the project since its inception.

By pursuing these aims, project investigators and contributors add to the usability, relevance, and robustness of a system and community that is unique and is uniquely situated to accelerate progress in many areas of genomic data science, ultimately contributing to biological knowledge and improvement of human health.
Funding Goals
NHGRI SUPPORTS THE DEVELOPMENT OF RESOURCES AND TECHNOLOGIES THAT WILL ACCELERATE GENOME RESEARCH AND ITS APPLICATION TO HUMAN HEALTH AND GENOMIC MEDICINE. A CRITICAL PART OF THE NHGRI MISSION CONTINUES TO BE THE STUDY OF THE ETHICAL, LEGAL AND SOCIAL IMPLICATIONS (ELSI) OF GENOME RESEARCH. NHGRI ALSO SUPPORTS THE TRAINING AND CAREER DEVELOPMENT OF INVESTIGATORS AND THE DISSEMINATION OF GENOME INFORMATION TO THE PUBLIC AND TO HEALTH PROFESSIONALS. THE SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM IS USED TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, TO INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION. THE SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM IS USED TO FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH AND DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO FOSTER TECHNOLOGY TRANSFER BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.
Grant Program (CFDA)
Place of Performance
Boston, Massachusetts 022155418 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the total obligations have increased 424% from $1,335,931 to $6,999,640.
Dana-Farber Cancer Institute was awarded Bioconductor: An Open-Source, Open-Development Computing Resource for Genomics Cooperative Agreement U24HG004059 worth $6,999,640 from National Human Genome Research Institute in September 2006 with work to be completed primarily in Boston Massachusetts United States. The grant has a duration of 19 years 5 months and was awarded through assistance program 93.172 Human Genome Research. The Cooperative Agreement was awarded through grant opportunity Genomic Community Resources (U24).

Status
(Ongoing)

Last Modified 5/5/25

Period of Performance
9/28/06
Start Date
2/28/26
End Date
98.0% Complete

Funding Split
$7.0M
Federal Obligation
$0.0
Non-Federal Obligation
$7.0M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U24HG004059

Subgrant Awards

Disclosed subgrants for U24HG004059

Transaction History

Modifications to U24HG004059

Additional Detail

Award ID FAIN
U24HG004059
SAI Number
U24HG004059-21625069
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75N400 NIH National Human Genome Research Institute
Funding Office
75N400 NIH National Human Genome Research Institute
Awardee UEI
DPMGH9MG1X67
Awardee CAGE
5E915
Performance District
MA-07
Senators
Edward Markey
Elizabeth Warren

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Human Genome Research Institute, National Institutes of Health, Health and Human Services (075-0891) Health research and training Grants, subsidies, and contributions (41.0) $2,643,737 92%
Office of the Director, National Institutes of Health, Health and Human Services (075-0846) Health research and training Grants, subsidies, and contributions (41.0) $227,504 8%
Modified: 5/5/25